Table 6.
Risk of rebleeding
| Risk of early rebleeding | Risk of late rebleeding | |||||
|---|---|---|---|---|---|---|
| Yes | No | p value | Yes | No | p value | |
| Antiplatelet drugs: yes/no | 5/19 | 46/102 | 0.3078 | 10/30 | 41/91 | 0.4622 |
| IVB before PPV: yes/no | 16/8 | 79/69 | 0.2245 | 18/22 | 77/55 | 0.1373 |
| IVB intraoperative: yes/no | 3/21 | 27/121 | 0.4915 | 11/29 | 19/113 | 0.5567 |
| Lower extremity amputation: yes/no | 2/22 | 26/122 | 0.2556 | 7/33 | 21/111 | 0.8112 |
| HBP: yes/no | 18/6 | 117/31 | 0.6538 | 35/5 | 100/32 | 0.1133 |
IVB= intravitreal Bevacizumab; PPV= pars plana vitrectomy; HBP= high blood pressure.